HSD3B1 and metastatic neoplasm: About half of all men with prostate cancer inherit at least 1 copy of the adrenal-permissive HSD3B1 allele, which is associated with more rapid ADT resistance and poorer survival in men with nonmetastatic disease and low-volume (LV) metastatic disease (6, 8).